Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.
Bayer and Merck & Co, Inc. said heart-failure drug candidate vericiguat didn't meet the primary target of a late-stage study. The German conglomerate on Monday said vericiguat in the phase 3 Victor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results